Social Responsibility

In 2018 EHS investment continued to increase, exceeding 54 million RMB,
"Diabetic Care" has served more than 1 million doctors and patients.

Corporate Citizen

Wanbang Biopharma has incorporated social responsibility into the long-term strategy of corporate development.
In the process of business development, Wanbang Biopharma has always been grateful.
Strive to be a company that satisfies society, government, employees and shareholders.

Diabetic Care Family

Bang Program

School-enterprise Cooperation

Xingbang Health Family

Rural Doctors

Earthquake Relief

Public Walfare

Wanbang Biopharma Public Lecture in Hengyang First People's Hospital.

2019.09.12

To improve the comprehensive management of chronic diseases, the public welfare project "NCD diagnosis and treatment training course" launched in Beijing

2019.03.30

Wang Health Action---Wanbang Biopharma together with Dashenlin established public health project.

2019.02.25